Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Roundup Cancer Trial Ends in Defense Verdict in Missouri Court It is the third Roundup cancer trial in Missouri which has ended in a defense verdict, and comes as the manufacturers face at least 10 additional jury trials nationwide in the coming months November 11, 2022 Irvin Jackson Add Your Comments Studies have linked chemicals in Roundup to non-Hodgkins lymphoma Following massive verdicts in 2018-2019, manufacturers agreed to pay more than $10 billion in Roundup settlements, but many cases remain unsettled A series of Roundup trials will be held over the coming months in multiple states As new cases of Roundup non-Hodgkins lymphoma continue to be diagnosed, lawyers continue to file claims nationwide FIND OUT IF YOU QUALIFY FOR A ROUNDUP CANCER LAWSUIT With a series of Roundup lawsuits set for trial to begin over the coming months, each involving similar allegations that the glyphosate-based weedkiller caused non-Hodgkins lymphoma, a Missouri jury returned a defense verdict this week in favor of the manufacturers. The Roundup trial involved a lawsuit filed by Stacey Moore, which went before a jury in the St. Louis County Circuit Court starting on October 21, and ended with a verdict in favor of Bayer and Mondanto on Wednesday. Like thousands of other consumers, Moore argued that her non-Hodgkin’s lymphoma diagnosis was directly caused by exposure to the chemicals in Roundup, pointing to a series of studies and evidence uncovered in recent years that glyphosate increases the risk of cancer. In 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) decided to classify glyphosate in Roundup as a probable cancer-causing agent, leading to more than 90,000 lawsuits filed over the past seven years. During the litigation, internal documents and evidence have been revealed that highlight Monsanto’s failure to disclose the cancer risks associated with their profitable weedkiller, and suggested that the company has covered up negative findings associated with glyphosate for decades, and manipulated study results involving the widely used weed killer. Following a series of massive juries awards in 2018 and 2019, Bayer agreed to pay $10 billion to settle about 120,000 Roundup product liability lawsuits. However, there are still thousands of claims left unresolved. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints brought in various different U.S. District Courts, the U.S. Judicial Panel on Multidistrict Litigation established a Roundup MDL in 2016, centralizing the claims before U.S. District Judge Vince Chhabria in the Northern District of California for coordinated discovery and a series of early “bellwether” trials to help gauge how juries are likely to respond to certain evidence and testimony that was repeated throughout the lawsuits. However, many of the cases have been filed in state courts in Missouri, California and Oregon. The verdict in Moore’s case is at least the third win this year for Monsanto in a Missouri court, where the company’s U.S. headquarters are located and it remains a major employer in the state. Another trial began last week in California Superior Court in San Francisco, and several more are scheduled through the end of this year and throughout 2023. The upcoming trial dates include: 11/29/2022 – Pied v. Monsanto in Hawaii Circuit Court (Hilo, Hawaii) 1/9/2023 – Griswold v. Monsanto in Missouri Circuit Court (St. Louis City) 1/23/2023 – Freiwald v. Monsanto in California Superior Court (San Francisco) 2/27/2023 – Chaplick v. Monsanto in Missouri Circuit Court (St. Louis County) 3/3/2023 – Weaver v. Monsanto in California Superior Court (San Diego) 4/3/2023 – Hedges v. Monsanto in Arizona Superior Court (Maricopa County) 4/24/2023 – Gordon v. Monsanto in Missouri Circuit Court (St. Louis County) 6/5/2023 – Lopez v. Monsanto in Florida Circuit Court (Wade County) 6/12/2023 – Moore v. Monsanto in Missouri County Circuit Court 6/26/2023 – Johnson v. Monsanto in California Superior Court (San Diego) Monsanto and Bayer are expected to face years of future litigation over Roundup, as unresolved claims work their way to trial and new lawsuit continue to be filed by individuals diagnosed with non-Hodgkin’s lymphoma who previously used the weed killer. To limit its future liability, Bayer announced last year that it will remove the active ingredient that causes cancer, glyphosate, from versions of the weed killer sold to U.S. residential customers by 2023. The products would still be sold under the Roundup label, but would use a different active ingredient, which has not been linked to a risk of non-Hodgkin’s lymphoma. However, glyphosate would still be used in products sold to agricultural businesses and farmers, and in product sold in other parts of the world, Bayer officials said. Tags: Bayer, Cancer, Herbicide, Missouri, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Georgia Lawmakers Agree To Shield Bayer From Roundup Cancer Lawsuits May 15, 2025 Roundup Exposure May Increase Infertility, Endometriosis Risks: Study May 1, 2025 Bayer Appeals Roundup Lawsuits to U.S. Supreme Court Again April 7, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)